Relationship between biopharmaceutical immunogenicity of epoetin alfa and pure red cell aplasia.
D000917:Antibody Formation / Q000187:drug effects*; D002626:Chemistry, Pharmaceutical; D004333:Drug Administration Routes; D004921:Erythropoietin / Q000009:adverse effects* / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*
D011994:Recombinant Proteins; D004921:Erythropoietin